Johnstone RM. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol Biochim et Biol Cell. 1992;70(3–4):179–90.
Bang C, Thum T. Exosomes: new gamers in cell-cell communication. Int J Biochem Cell Biol. 2012;44(11):2060–4.
Brown C, McKee C, Bakshi S, Walker Ok, Hakman E, Halassy S, et al. Mesenchymal stem cells: cell remedy and regeneration potential. J Tissue Eng Regen Med. 2019;13(9):1738–55.
Hade MD, Suire CN, Suo Z. Mesenchymal stem cell-derived exosomes: functions in regenerative drugs. Cells. 2021;10(8):1959.
Fernández-Francos S, Eiro N, González-Galiano N, Vizoso FJ. Mesenchymal stem cell-based remedy as a substitute for the remedy of acute respiratory misery syndrome: present proof and future views. Int J Mol Sci. 2021;22(15):7850.
Nassar W, El-Ansary M, Sabry D, Mostafa MA, Fayad T, Kotb E, et al. Umbilical wire mesenchymal stem cells derived extracellular vesicles can safely ameliorate the development of continual kidney ailments. Biomater Res. 2016;20:21.
Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, et al. Extracellular vesicles as drug supply techniques: why and the way? Adv Drug Deliv Rev. 2020;159:332–43.
Peng H, Ji W, Zhao R, Yang J, Lu Z, Li Y, et al. Exosome: a big nano-scale drug supply provider. J Mater Chem B. 2020;8(34):7591–608.
Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in most cancers metastasis and drug resistance. Mol Most cancers. 2019;18(1):75.
Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-mediated metastasis: communication from a distance. Dev Cell. 2019;49(3):347–60.
Kang M, Jordan V, Blenkiron C, Chamley LW. Biodistribution of extracellular vesicles following administration into animals: a scientific overview. J Extracell Vesicles. 2021;10(8): e12085.
Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and supply effectivity of unmodified tumor-derived exosomes. J Management Launch. 2015;199:145–55.
Salunkhe S, Dheeraj, Basak M, Chitkara D, Mittal A. Floor functionalization of exosomes for target-specific supply and in vivo imaging & monitoring: methods and significance. J Management Launch. 2020;326:599–614.
Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for focused drug supply. Theranostics. 2021;11(7):3183–95.
Richter M, Vader P, Fuhrmann G. Approaches to floor engineering of extracellular vesicles. Adv Drug Deliv Rev. 2021;173:416–26.
Deng F, Wang S, Xu R, Yu W, Wang X, Zhang L. Endothelial microvesicles in hypoxic hypoxia ailments. J Cell Mol Med. 2018;22(8):3708–18.
Li KY, Zheng L, Wang Q, Hu YW. Traits of erythrocyte-derived microvesicles and its relation with atherosclerosis. Atherosclerosis. 2016;255:140–4.
Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, et al. Extracellular vesicles: the following era theranostic nanomedicine for inflammatory bowel illness. Int J Nanomed. 2022;17:3893–911.
Shu Z, Tan J, Miao Y, Zhang Q. The function of microvesicles containing microRNAs in vascular endothelial dysfunction. J Cell Mol Med. 2019;23(12):7933–45.
Lv Y, Tan J, Miao Y, Zhang Q. The function of microvesicles and its lively molecules in regulating mobile biology. J Cell Mol Med. 2019;23(12):7894–904.
Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014;29:116–25.
Aheget H, Tristán-Manzano M, Mazini L, Cortijo-Gutierrez M, Galindo-Moreno P, Herrera C, et al. Exosome: a brand new participant in translational nanomedicine. J Clin Med. 2020;9(8):2380.
Kenific CM, Zhang H, Lyden D. An exosome pathway with out an ESCRT. Cell Res. 2021;31(2):105–6.
Christ L, Raiborg C, Wenzel EM, Campsteijn C, Stenmark H. Mobile capabilities and molecular mechanisms of the ESCRT membrane-scission equipment. Developments Biochem Sci. 2017;42(1):42–56.
Trajkovic Ok, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science (New York, NY). 2008;319(5867):1244–7.
Perez-Hernandez D, Gutiérrez-Vázquez C, Jorge I, López-Martín S, Ursa A, Sánchez-Madrid F, et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their perform as sorting machineries towards exosomes. J Biol Chem. 2013;288(17):11649–61.
van Niel G, D’Angelo G, Raposo G. Shedding gentle on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–28.
Witwer KW, Théry C. Extracellular vesicles or exosomes? On primacy, precision, and recognition influencing a selection of nomenclature. J Extracell Vesicles. 2019;8(1):1648167.
Zöller M. Exosomes in Most cancers Illness. Strategies Mol Biol (Clifton, NJ). 2016;1381:111–49.
Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Sign. 2021;19(1):47.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal info for research of extracellular vesicles 2018 (MISEV2018): a place assertion of the Worldwide Society for Extracellular Vesicles and replace of the MISEV2014 tips. J Extracell Vesicles. 2018;7(1):1535750.
Frankel EB, Audhya A. ESCRT-dependent cargo sorting at multivesicular endosomes. Semin Cell Dev Biol. 2018;74:4–10.
Babst M. MVB vesicle formation: ESCRT-dependent, ESCRT-independent and every thing in between. Curr Opin Cell Biol. 2011;23(4):452–7.
Bister N, Pistono C, Huremagic B, Jolkkonen J, Giugno R, Malm T. Hypoxia and extracellular vesicles: a overview on strategies, vesicular cargo and capabilities. J Extracell Vesicles. 2020;10(1): e12002.
Rong Y, Zhang J, Jiang D, Ji C, Liu W, Wang J, et al. Hypoxic pretreatment of small extracellular vesicles mediates cartilage restore in osteoarthritis by delivering miR-216a-5p. Acta Biomater. 2021;122:325–42.
Jadli AS, Ballasy N, Edalat P, Patel VB. Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake. Mol Cell Biochem. 2020;467(1–2):77–94.
Gonda A, Kabagwira J, Senthil GN, Wall NR. Internalization of exosomes by means of receptor-mediated endocytosis. Mol Most cancers Res MCR. 2019;17(2):337–47.
Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J. Mature dendritic cells pulsed with exosomes stimulate environment friendly cytotoxic T-lymphocyte responses and antitumour immunity. Immunology. 2007;120(1):90–102.
Saunderson SC, Dunn AC, Crocker PR, McLellan AD. CD169 mediates the seize of exosomes in spleen and lymph node. Blood. 2014;123(2):208–16.
Shimoda A, Tahara Y, Sawada SI, Sasaki Y, Akiyoshi Ok. Glycan profiling evaluation utilizing evanescent-field fluorescence-assisted lectin array: significance of sugar recognition for mobile uptake of exosomes from mesenchymal stem cells. Biochem Biophys Res Commun. 2017;491(3):701–7.
Zech D, Rana S, Büchler MW, Zöller M. Tumor-exosomes and leukocyte activation: an ambivalent crosstalk. Cell Commun Sign. 2012;10(1):37.
Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, et al. Macrophage exosomes as pure nanocarriers for protein supply to infected mind. Biomaterials. 2017;142:1–12.
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins decide organotropic metastasis. Nature. 2015;527(7578):329–35.
Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Most cancers cell exosomes rely upon cell-surface heparan sulfate proteoglycans for his or her internalization and purposeful exercise. Proc Natl Acad Sci USA. 2013;110(43):17380–5.
Purushothaman A, Bandari SK, Liu J, Mobley JA, Brown EE, Sanderson RD. Fibronectin on the floor of myeloma cell-derived exosomes mediates exosome-cell interactions. J Biol Chem. 2016;291(4):1652–63.
Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, et al. Sensing of latent EBV an infection by means of exosomal switch of 5’pppRNA. Proc Natl Acad Sci USA. 2016;113(5):E587–96.
Nakase I, Futaki S. Mixed remedy with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic supply of exosomes. Sci Rep. 2015;5:10112.
Shah N, Ishii M, Brandon C, Ablonczy Z, Cai J, Liu Y, et al. Extracellular vesicle-mediated long-range communication in burdened retinal pigment epithelial cell monolayers. Biochim Biophys Acta. 2018;1864(8):2610–22.
Kalluri R. The biology and performance of exosomes in most cancers. J Clin Investig. 2016;126(4):1208–15.
Koch R, Aung T, Vogel D, Chapuy B, Wenzel D, Becker S, et al. Nuclear trapping by means of inhibition of exosomal export by indomethacin will increase cytostatic efficacy of doxorubicin and pixantrone. Clin Most cancers Res. 2016;22(2):395–404.
Yu W, Hurley J, Roberts D, Chakrabortty SK, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in most cancers: alternatives and challenges. Ann Oncol. 2021;32(4):466–77.
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, et al. Glypican-1 identifies most cancers exosomes and detects early pancreatic most cancers. Nature. 2015;523(7559):177–82.
Phinney DG, Pittenger MF. Concise overview: MSC-derived exosomes for cell-free remedy. Stem cells (Dayton, Ohio). 2017;35(4):851–8.
Tian CM, Yang MF, Xu HM, Zhu MZ, Zhang Y, Yao J, et al. Mesenchymal stem cell-derived exosomes: novel therapeutic method for inflammatory bowel ailments. Stem Cells Int. 2023;2023:4245704.
Fu W, Lei C, Liu S, Cui Y, Wang C, Qian Ok, et al. CAR exosomes derived from effector CAR-T cells have potent antitumour results and low toxicity. Nat Commun. 2019;10(1):4355.
Shao J, Zaro J, Shen Y. Advances in exosome-based drug supply and tumor concentrating on: from tissue distribution to intracellular destiny. Int J Nanomed. 2020;15:9355–71.
Antimisiaris SG, Mourtas S, Marazioti A. Exosomes and exosome-inspired vesicles for focused drug supply. Pharmaceutics. 2018;10(4):218.
Lou G, Track X, Yang F, Wu S, Wang J, Chen Z, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs improve chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122.
Ma X, Wang J, Li J, Ma C, Chen S, Lei W, et al. Loading MiR-210 in endothelial progenitor cells derived exosomes boosts their helpful results on hypoxia/reoxygeneation-injured human endothelial cells through defending mitochondrial perform. Cell Physiol Biochem. 2018;46(2):664–75.
Yang Z, Yang Y, Xu Y, Jiang W, Shao Y, Xing J, et al. Biomimetic nerve steerage conduit containing engineered exosomes of adipose-derived stem cells promotes peripheral nerve regeneration. Stem Cell Res Ther. 2021;12(1):442.
Kojima R, Bojar D, Rizzi G, Hamri GC, El-Baba MD, Saxena P, et al. Designer exosomes produced by implanted cells intracerebrally ship therapeutic cargo for Parkinson’s illness remedy. Nat Commun. 2018;9(1):1305.
Hung ME, Leonard JN. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated supply. J Extracell Vesicles. 2016;5:31027.
Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, et al. LAMP2A regulates the loading of proteins into exosomes. Sci Adv. 2022;8(12):eabm1140.
Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, et al. Paclitaxel is included by mesenchymal stromal cells and launched in exosomes that inhibit in vitro tumor development: a brand new method for drug supply. J Management Launch. 2014;192:262–70.
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wooden MJ. Supply of siRNA to the mouse mind by systemic injection of focused exosomes. Nat Biotechnol. 2011;29(4):341–5.
Zhuang X, Xiang X, Grizzle W, Solar D, Zhang S, Axtell RC, et al. Remedy of mind inflammatory ailments by delivering exosome encapsulated anti-inflammatory medicine from the nasal area to the mind. Mol Ther. 2011;19(10):1769–79.
Didiot MC, Corridor LM, Coles AH, Haraszti RA, Godinho BM, Chase Ok, et al. Exosome-mediated supply of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther. 2016;24(10):1836–47.
Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as drug supply autos for Parkinson’s illness remedy. J Management Launch. 2015;207:18–30.
Betzer O, Perets N, Angel A, Motiei M, Sadan T, Yadid G, et al. In vivo neuroimaging of exosomes utilizing gold nanoparticles. ACS Nano. 2017;11(11):10883–93.
Lamichhane TN, Jeyaram A, Patel DB, Parajuli B, Livingston NK, Arumugasaamy N, et al. Oncogene knockdown through lively loading of small RNAs into extracellular vesicles by sonication. Cell Mol Bioeng. 2016;9(3):315–24.
Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, et al. Improvement of exosome-encapsulated paclitaxel to beat MDR in most cancers cells. Nanomed Nanotechnol Biol Med. 2016;12(3):655–64.
Goh WJ, Lee CK, Zou S, Woon EC, Czarny B, Pastorin G. Doxorubicin-loaded cell-derived nanovesicles: another focused method for anti-tumor remedy. Int J Nanomed. 2017;12:2759–67.
Podolak I, Galanty A, Sobolewska D. Saponins as cytotoxic brokers: a overview. Phytochem Rev. 2010;9(3):425–74.
Xi XM, Xia SJ, Lu R. Drug loading methods for exosome-based drug supply techniques. Pharmazie. 2021;76(2):61–7.
Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Lively loading into extracellular vesicles considerably improves the mobile uptake and photodynamic impact of porphyrins. J Management Launch. 2015;205:35–44.
Barile L, Vassalli G. Exosomes: remedy supply instruments and biomarkers of ailments. Pharmacol Ther. 2017;174:63–78.
Terstappen GC, Meyer AH, Bell RD, Zhang W. Methods for delivering therapeutics throughout the blood-brain barrier. Nat Rev Drug Discov. 2021;20(5):362–83.
Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, et al. Engineering macrophage-derived exosomes for focused paclitaxel supply to pulmonary metastases: in vitro and in vivo evaluations. Nanomed Nanotechnol Biol Med. 2018;14(1):195–204.
Yang T, Martin P, Fogarty B, Brown A, Schurman Ok, Phipps R, et al. Exosome delivered anticancer medicine throughout the blood-brain barrier for mind most cancers remedy in Danio rerio. Pharm Res. 2015;32(6):2003–14.
Wang H, Sui H, Zheng Y, Jiang Y, Shi Y, Liang J, et al. Curcumin-primed exosomes potently ameliorate cognitive perform in AD mice by inhibiting hyperphosphorylation of the Tau protein by means of the AKT/GSK-3β pathway. Nanoscale. 2019;11(15):7481–96.
Kalani A, Chaturvedi P, Kamat PK, Maldonado C, Bauer P, Joshua IG, et al. Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion damage. Int J Biochem Cell Biol. 2016;79:360–9.
Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, et al. Floor functionalized exosomes as focused drug supply autos for cerebral ischemia remedy. Biomaterials. 2018;150:137–49.
Kumar Giri T, Giri A, Kumar Barman T, Maity S. Nanoliposome is a promising provider of protein and peptide biomolecule for the remedy of most cancers. Anticancer Brokers Med Chem. 2016;16(7):816–31.
Jash A, Ubeyitogullari A, Rizvi SSH. Liposomes for oral supply of protein and peptide-based therapeutics: challenges, formulation methods, and advances. J Mater Chem B. 2021;9(24):4773–92.
Ryan BM, O’Donovan N, Duffy MJ. Survivin: a brand new goal for anti-cancer remedy. Most cancers Deal with Rev. 2009;35(7):553–62.
Aspe JR, Diaz Osterman CJ, Jutzy JM, Deshields S, Whang S, Wall NR. Enhancement of gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated supply of the Survivin-T34A mutant. J Extracell Vesicles. 2014;3:23244.
Szabó GT, Mahiny AJ, Vlatkovic I. COVID-19 mRNA vaccines: Platforms and present developments. Mol Ther. 2022;30(5):1850–68.
Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010;38(1):215–24.
Nikam RR, Gore KR. Journey of siRNA: medical developments and focused supply. Nucleic Acid Ther. 2018;28(4):209–24.
Zhou Y, Yuan Y, Liu M, Hu X, Quan Y, Chen X. Tumor-specific supply of KRAS siRNA with iRGD-exosomes effectively inhibits tumor development. ExRNA. 2019;1(1):28.
Liang Y, Iqbal Z, Lu J, Wang J, Zhang H, Chen X, et al. Cell-derived nanovesicle-mediated drug supply to the mind: rules and methods for vesicle engineering. Mol Ther. 2023;31(5):1207–24.
Kim M, Kim G, Hwang DW, Lee M. Supply of excessive mobility group Field-1 siRNA utilizing brain-targeting exosomes for ischemic stroke remedy. J Biomed Nanotechnol. 2019;15(12):2401–12.
Khalaj Ok, Figueira RL, Antounians L, Lauriti G, Zani A. Systematic overview of extracellular vesicle-based remedies for lung damage: are EVs a possible remedy for COVID-19? J Extracell Vesicles. 2020;9(1):1795365.
Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells improve cartilage tissue regeneration and stop osteoarthritis of the knee in a rat mannequin. Theranostics. 2017;7(1):180–95.
Ohno S, Takanashi M, Sudo Ok, Ueda S, Ishikawa A, Matsuyama N, et al. Systemically injected exosomes focused to EGFR ship antitumor microRNA to breast most cancers cells. Mol Ther. 2013;21(1):185–91.
Sahin U, Karikó Ok, Türeci Ö. mRNA-based therapeutics–growing a brand new class of medication. Nat Rev Drug Discov. 2014;13(10):759–80.
Li DF, Liu QS, Yang MF, Xu HM, Zhu MZ, Zhang Y, et al. Nanomaterials for mRNA-based therapeutics: challenges and alternatives. Bioeng Transl Med. 2023;8(3): e10492.
Massive EE, Silveria MA, Zane GM, Weerakoon O, Chapman MS. Adeno-Related Virus (AAV) gene supply: dissecting molecular interactions upon cell entry. Viruses. 2021;13(7):1336.
Meliani A, Boisgerault F, Fitzpatrick Z, Marmier S, Leborgne C, Collaud F, et al. Enhanced liver gene switch and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Adv. 2017;1(23):2019–31.
Khan N, Maurya S, Bammidi S, Jayandharan GR. AAV6 Vexosomes mediate strong suicide gene supply in a murine mannequin of hepatocellular carcinoma. Mol Ther Strategies Clin Dev. 2020;17:497–504.
Luther DC, Lee YW, Nagaraj H, Scaletti F, Rotello VM. Supply approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges. Skilled Opin Drug Deliv. 2018;15(9):905–13.
Iqbal Z, Rehman Ok, Xia J, Shabbir M, Zaman M, Liang Y, et al. Biomaterial-assisted focused and managed supply of CRISPR/Cas9 for exact gene modifying. Biomater Sci. 2023;11(11):3762–83.
Duan L, Ouyang Ok, Wang J, Xu L, Xu X, Wen C, et al. Exosomes as focused supply platform of CRISPR/Cas9 for therapeutic genome modifying. Chembiochem Eur J Chem Biol. 2021;22(24):3360–8.
Duan L, Ouyang Ok, Xu X, Xu L, Wen C, Zhou X, et al. Nanoparticle supply of CRISPR/Cas9 for genome modifying. Entrance Genet. 2021;12: 673286.
Liang Y, Iqbal Z, Wang J, Xu L, Xu X, Ouyang Ok, et al. Cell-derived extracellular vesicles for CRISPR/Cas9 supply: engineering methods for cargo packaging and loading. Biomater Sci. 2022;10(15):4095–106.
Kim SM, Yang Y, Oh SJ, Hong Y, Website positioning M, Jang M. Most cancers-derived exosomes as a supply platform of CRISPR/Cas9 confer most cancers cell tropism-dependent concentrating on. J Management Launch. 2017;266:8–16.
Gee P, Lung MSY, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y, et al. Extracellular nanovesicles for packaging of CRISPR–Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat Commun. 2020;11(1):1334.
Osteikoetxea X, Silva A, Lázaro-Ibáñez E, Salmond N, Shatnyeva O, Stein J, et al. Engineered Cas9 extracellular vesicles as a novel gene modifying software. J Extracell Vesicles. 2022;11(5): e12225.
Liu Y, Li D, Liu Z, Zhou Y, Chu D, Li X, et al. Focused exosome-mediated supply of opioid receptor Mu siRNA for the remedy of morphine relapse. Sci Rep. 2015;5:17543.
Yang J, Zhang X, Chen X, Wang L, Yang G. Exosome mediated supply of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic acids. 2017;7:278–87.
Yang J, Wu S, Hou L, Zhu D, Yin S, Yang G, et al. Therapeutic results of simultaneous supply of nerve development issue mRNA and protein through exosomes on cerebral ischemia. Mol Ther Nucleic Acids. 2020;21:512–22.
Yu X, Bai Y, Han B, Ju M, Tang T, Shen L, et al. Extracellular vesicle-mediated supply of circDYM alleviates CUS-induced depressive-like behaviours. J Extracell Vesicles. 2022;11(1): e12185.
Yang L, Han B, Zhang Z, Wang S, Bai Y, Zhang Y, et al. Extracellular vesicle-mediated supply of round RNA SCMH1 promotes purposeful restoration in rodent and nonhuman primate ischemic stroke fashions. Circulation. 2020;142(6):556–74.
Ren X, Zhao Y, Xue F, Zheng Y, Huang H, Wang W, et al. Exosomal DNA aptamer concentrating on α-synuclein aggregates lowered neuropathological deficits in a mouse Parkinson’s illness mannequin. Mol Ther Nucleic Acids. 2019;17:726–40.
Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic supply of microRNA-21 antisense oligonucleotides to the mind utilizing T7-peptide embellished exosomes. J Management Launch. 2020;317:273–81.
Liang Y, Xu X, Li X, Xiong J, Li B, Duan L, et al. Chondrocyte-targeted MicroRNA supply by engineered exosomes towards a cell-free osteoarthritis remedy. ACS Appl Mater Interfaces. 2020;12(33):36938–47.
Xu X, Liang Y, Li X, Ouyang Ok, Wang M, Cao T, et al. Exosome-mediated supply of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021;269: 120539.
Zhao Z, Shuang T, Gao Y, Lu F, Zhang J, He W, et al. Focused supply of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization. Most cancers Lett. 2022;530:45–58.
Li X, Yu Q, Zhao R, Guo X, Liu C, Zhang Ok, et al. Designer exosomes for focused supply of a novel therapeutic cargo to boost sorafenib-mediated ferroptosis in hepatocellular carcinoma. Entrance Oncol. 2022;12: 898156.
Bai J, Duan J, Liu R, Du Y, Luo Q, Cui Y, et al. Engineered concentrating on tLyp-1 exosomes as gene remedy vectors for environment friendly supply of siRNA into lung most cancers cells. Asian J Pharm Sci. 2020;15(4):461–71.
Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si Ok, et al. Engineered exosomes for focused co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon most cancers. J Nanobiotechnol. 2020;18(1):10.
Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S. Engineered exosome-mediated supply of functionally lively miR-26a and its enhanced suppression impact in HepG2 cells. Int J Nanomed. 2018;13:585–99.
Choi H, Choi Ok, Kim DH, Oh BK, Yim H, Jo S, et al. Methods for focused supply of exosomes to the mind: benefits and challenges. Pharmaceutics. 2022;14(3):672.
Ho M, Nagata S, Pastan I. Isolation of anti-CD22 Fv with excessive affinity by Fv show on human cells. Proc Natl Acad Sci USA. 2006;103(25):9637–42.
Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming exosomes as nanoscale controllers of mobile immunity. J Am Chem Soc. 2018;140(48):16413–7.
Cheng Q, Dai Z, Smbatyan G, Epstein AL, Lenz HJ, Zhang Y. Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes. Molecular Ther. 2022;30:3066–77.
Kim DK, Nishida H, An SY, Shetty AK, Bartosh TJ, Prockop DJ. Chromatographically remoted CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI. Proc Natl Acad Sci USA. 2016;113(1):170–5.
Kugeratski FG, Hodge Ok, Lilla S, McAndrews KM, Zhou X, Hwang RF, et al. Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the very best considerable protein and a putative common biomarker. Nat Cell Biol. 2021;23(6):631–41.
Gupta D, Wiklander OPB, Görgens A, Conceição M, Corso G, Liang X, et al. Amelioration of systemic irritation through the show of two totally different decoy protein receptors on extracellular vesicles. Nat Biomed Eng. 2021;5(9):1084–98.
Lewis ND, Sia CL, Kirwin Ok, Haupt S, Mahimkar G, Zi T, et al. Exosome floor show of IL12 ends in tumor-retained pharmacology with superior efficiency and restricted systemic publicity in contrast with recombinant IL12. Mol Most cancers Ther. 2021;20(3):523–34.
Liu M, Hu Y, Chen G. The antitumor impact of gene-engineered exosomes within the remedy of mind metastasis of breast most cancers. Entrance Oncol. 2020;10:1453.
Dasgupta SK, Abdel-Monem H, Guchhait P, Nagata S, Thiagarajan P. Function of lactadherin within the clearance of phosphatidylserine-expressing purple blood cells. Transfusion. 2008;48(11):2370–6.
Rountree RB, Mandl SJ, Nachtwey JM, Dalpozzo Ok, Do L, Lombardo JR, et al. Exosome concentrating on of tumor antigens expressed by most cancers vaccines can enhance antigen immunogenicity and therapeutic efficacy. Can Res. 2011;71(15):5235–44.
Wang JH, Forterre AV, Zhao J, Frimannsson DO, Delcayre A, Antes TJ, et al. Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene supply inhibits development of HER2-positive human breast tumor xenografts by prodrug activation. Mol Most cancers Ther. 2018;17(5):1133–42.
Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Show of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell concentrating on. J Extracell Vesicles. 2016;5:31053.
Wang J, Li W, Lu Z, Zhang L, Hu Y, Li Q, et al. The usage of RGD-engineered exosomes for enhanced concentrating on potential and synergistic remedy towards angiogenesis. Nanoscale. 2017;9(40):15598–605.
Wu JY, Li YJ, Wang J, Hu XB, Huang S, Luo S, et al. Multifunctional exosome-mimetics for focused anti-glioblastoma remedy by manipulating protein corona. J Nanobiotechnol. 2021;19(1):405.
Liang SF, Zuo FF, Yin BC, Ye BC. Supply of siRNA primarily based on engineered exosomes for glioblastoma remedy by concentrating on STAT3. Biomater Sci. 2022;10(6):1582–90.
Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue reminiscence deficits by regulating inflammatory responses in a mouse mannequin of Alzheimer’s illness. Immunity Ageing I & A. 2019;16:10.
Wang Y, Chen X, Tian B, Liu J, Yang L, Zeng L, et al. Nucleolin-targeted extracellular vesicles as a flexible platform for biologics supply to breast most cancers. Theranostics. 2017;7(5):1360–72.
Pi F, Binzel DW, Lee TJ, Li Z, Solar M, Rychahou P, et al. Nanoparticle orientation to regulate RNA loading and ligand show on extracellular vesicles for most cancers regression. Nat Nanotechnol. 2018;13(1):82–9.
Zou J, Shi M, Liu X, Jin C, Xing X, Qiu L, et al. Aptamer-functionalized exosomes: elucidating the mobile uptake mechanism and the potential for cancer-targeted chemotherapy. Anal Chem. 2019;91(3):2425–30.
Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J, et al. Aptamer-conjugated extracellular nanovesicles for focused drug supply. Can Res. 2018;78(3):798–808.
Jia G, Han Y, An Y, Ding Y, He C, Wang X, et al. NRP-1 focused and cargo-loaded exosomes facilitate simultaneous imaging and remedy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–16.
Zhang H, Wu J, Wu J, Fan Q, Zhou J, Wu J, et al. Exosome-mediated focused supply of miR-210 for angiogenic remedy after cerebral ischemia in mice. J Nanobiotechnol. 2019;17(1):29.
Roberts-Dalton HD, Cocks A, Falcon-Perez JM, Sayers EJ, Webber JP, Watson P, et al. Fluorescence labelling of extracellular vesicles utilizing a novel thiol-based technique for quantitative evaluation of mobile supply and intracellular site visitors. Nanoscale. 2017;9(36):13693–706.
Wang M, Altinoglu S, Takeda YS, Xu Q. Integrating protein engineering and bioorthogonal click on conjugation for extracellular vesicle modulation and intracellular supply. PLoS ONE. 2015;10(11): e0141860.
Lee TS, Kim Y, Zhang W, Track IH, Tung CH. Facile metabolic glycan labeling technique for exosome monitoring. Biochim Biophys Acta. 2018;1862(5):1091–100.
Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q, et al. Anchor peptide captures, targets, and hundreds exosomes of numerous origins for diagnostics and remedy. Sci Transl Med. 2018;10(444):eaat0195.
Xu L, Xu X, Liang Y, Wen C, Ouyang Ok, Huang J, et al. Osteoclast-targeted supply of anti-miRNA oligonucleotides by purple blood cell extracellular vesicles. J Management Launch. 2023;358:259–72.
Guo Y, Wan Z, Zhao P, Wei M, Liu Y, Bu T, et al. Ultrasound triggered topical supply of Bmp7 mRNA for white fats browning induction through engineered good exosomes. J Nanobiotechnol. 2021;19(1):402.
Dong X, Lei Y, Yu Z, Wang T, Liu Y, Han G, et al. Exosome-mediated supply of an anti-angiogenic peptide inhibits pathological retinal angiogenesis. Theranostics. 2021;11(11):5107–26.
Qi H, Liu C, Lengthy L, Ren Y, Zhang S, Chang X, et al. Blood exosomes endowed with magnetic and concentrating on properties for most cancers remedy. ACS Nano. 2016;10(3):3323–33.
Wan S, Zhang L, Wang S, Liu Y, Wu C, Cui C, et al. Molecular recognition-based DNA nanoassemblies on the surfaces of nanosized exosomes. J Am Chem Soc. 2017;139(15):5289–92.
Rehm FBH, Harmand TJ, Yap Ok, Durek T, Craik DJ, Ploegh HL. Website-specific sequential protein labeling catalyzed by a single recombinant ligase. J Am Chem Soc. 2019;141(43):17388–93.
Pham TC, Jayasinghe MK, Pham TT, Yang Y, Wei L, Usman WM, et al. Covalent conjugation of extracellular vesicles with peptides and nanobodies for focused therapeutic supply. J Extracell Vesicles. 2021;10(4): e12057.
Kooijmans SAA, Gitz-Francois J, Schiffelers RM, Vader P. Recombinant phosphatidylserine-binding nanobodies for concentrating on of extracellular vesicles to tumor cells: a plug-and-play method. Nanoscale. 2018;10(5):2413–26.
Tian T, Cao L, He C, Ye Q, Liang R, You W, et al. Focused supply of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021;11(13):6507–21.
Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, et al. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian most cancers. J Nanobiotechnol. 2022;20(1):50.
Cheng L, Zhang X, Tang J, Lv Q, Liu J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 sign for mixed photothermal remedy and most cancers immunotherapy. Biomaterials. 2021;275: 120964.
Lv Q, Cheng L, Lu Y, Zhang X, Wang Y, Deng J, et al. Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved remedy of metastatic peritoneal most cancers. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2020;7(18):2000515.
Yin J, Straight PD, McLoughlin SM, Zhou Z, Lin AJ, Golan DE, et al. Genetically encoded quick peptide tag for versatile protein labeling by Sfp phosphopantetheinyl transferase. Proc Natl Acad Sci USA. 2005;102(44):15815–20.
Wilhelm J, Kühn S, Tarnawski M, Gotthard G, Tünnermann J, Tänzer T, et al. Kinetic and structural characterization of the self-labeling protein tags HaloTag7, SNAP-tag, and CLIP-tag. Biochemistry. 2021;60(33):2560–75.
Los GV, Encell LP, McDougall MG, Hartzell DD, Karassina N, Zimprich C, et al. HaloTag: a novel protein labeling expertise for cell imaging and protein evaluation. ACS Chem Biol. 2008;3(6):373–82.
Cole NB. Website-specific protein labeling with SNAP-tags. Curr Protoc Protein Sci. 2013;73:30.1.1-1.16.
Wang XW, Zhang WB. SpyTag-SpyCatcher chemistry for protein bioconjugation in vitro and protein topology engineering in vivo. Strategies Mol Biol (Clifton, NJ). 2019;2033:287–300.
Hatlem D, Trunk T, Linke D, Leo JC. Catching a SPY: utilizing the SpyCatcher-SpyTag and associated techniques for labeling and localizing bacterial proteins. Int J Mol Sci. 2019;20(9):2129.
Manandhar M, Chun E, Romesberg FE. Genetic code enlargement: inception, improvement, commercialization. J Am Chem Soc. 2021;143(13):4859–78.
Yamashita T, Takahashi Y, Takakura Y. Risk of exosome-based therapeutics and challenges in manufacturing of exosomes eligible for therapeutic software. Biol Pharm Bull. 2018;41(6):835–42.
Wang J, Chen D, Ho EA. Challenges within the improvement and institution of exosome-based drug supply techniques. J Management Launch. 2021;329:894–906.
Liang Y, Xu X, Xu L, Iqbal Z, Ouyang Ok, Zhang H, et al. Chondrocyte-specific genomic modifying enabled by hybrid exosomes for osteoarthritis remedy. Theranostics. 2022;12(11):4866–78.
